1 Min Read
Nov 23 (Reuters) - Biocon Ltd:
* Launches Krabeva - biosimilar Bevacizumab for treating several types of cancer in India
Source text - bit.ly/2jOug4x
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.